Mount Sinai Health System Names New Chair of Neurology
Renowned neurologist Barbara G. Vickrey, MD, MPH, has been named System Chair for the Department of Neurology at the Icahn School of Medicine at Mount Sinai, with her new role to begin on Oct. 1, 2015.
Renowned neurologist Barbara G. Vickrey, MD, MPH, has been named System Chair for the Department of Neurology at the Icahn School of Medicine at Mount Sinai, with her new role to begin on Oct. 1, 2015.
Dr. Vickrey specializes in translating clinical evidence into improvements in routine medical practice that improve patients’ health. Her wide-ranging accomplishments include demonstrating that collaboration among healthcare systems, community organizations and caregivers can improve quality of care and outcomes for dementia patients. She also designed healthcare delivery innovations ranging from better control of post-stroke risk factors in underserved populations to new ways to care for veterans with Parkinson's disease.
“We are delighted to welcome Dr. Vickrey to the Mount Sinai Health System, knowing that she brings unique expertise to the Department of Neurology,” said Mount Sinai President and Chief Executive Officer Kenneth L. Davis, MD. “She will be a tremendous mentor for the next generation of neurologists and health policymakers here in line with our goal of providing superior care to all.”
In terms of national leadership, Dr. Vickrey was elected to the Institute of Medicine of the National Academies in 2011, one of the highest honors in academic medicine. She also leads a five-year, stroke prevention/intervention research program in health disparities funded by the National Institute of Neurological Disorders and Stroke (NINDS). She serves on the Science Committee of the American Academy of Neurology and is Vice President of the American Neurological Association.
“Dr. Vickrey’s outstanding research dovetails with efforts throughout the Mount Sinai Health System and presents exciting opportunities for collaborative research across our academic departments,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai. “Her contribution will go beyond Neurology as she enlivens collaborations with Population Health Science and Policy, Geriatrics and Palliative Medicine, the Mount Sinai Institute of Technology and the Institute for Healthcare Delivery Science,” said Dr. Charney, also President for Academic Affairs for the Health System
Dr. Vickrey has served for 25 years on the faculty of the University of California, Los Angeles (UCLA), where she is Professor of Neurology and Director of the departmental Health Services Research Program. She is also Associate Director for Research at the Greater Los Angeles Veterans Administration Parkinson’s Disease Research, Education and Clinical Center.
Dr. Vickrey earned her MD degree at Duke University School of Medicine and her MPH at the UCLA School of Public Health. She completed postgraduate clinical training in medicine and neurology at the University of Washington in Seattle, and then research fellowships in the Robert Wood Johnson Clinical Scholars Program at UCLA and the RAND/UCLA Center for Health Policy Study.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Two Mount Sinai Experts Receive Honors From the National Multiple Sclerosis Society
Sep 16, 2021 View All Press Releases